Laying Out Advances in ADC Development & Manufacturing

• Discussing tools used for the efficient and scalable manufacturing of the mAb intermediate, which serves as a key starting point for ADC conjugation
• Overcoming ADC mAb diversity challenges via AI-driven cell line design
• Explaining operator safety risk-mitigation enabled by agnostic, automated solutions

Speakers:

Sean Muthian

General Manager - Customer Portfolio Strategy

Cytiva